Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.
about
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@ast
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@en
type
label
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@ast
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@en
prefLabel
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@ast
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@en
P2093
P2860
P1476
Phase 1 dose de-escalation tri ...... with resectable rectal cancer.
@en
P2093
Bengt Gustavsson
Elisabeth Odin
Fernando Gibson
Göran Carlsson
Göran Kurlberg
Hillevi Björkqvist
Kristoffer Derwinger
Torbjörn Swartling
P2860
P2888
P304
P356
10.1007/S10637-015-0272-0
P577
2015-07-21T00:00:00Z